The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials
Open accessAbstract
Objective: To compare glycaemic control and insulin dosage in people with type 1 diabetes treated by continuous subcutaneous insulin infusion (insulin infusion pump therapy) or optimised insulin injections. Design: Meta-analysis of 12 randomised controlled trials. Participants: 301 people with type 1 diabetes allocated to insulin infusion and 299 allocated to insulin injections for between 2.5 and 24 months. Main outcome measures: Glycaemic control measured by mean blood glucose concentration and percentage of glycated haemoglobin. Total daily insulin dose. Results: Mean blood glucose concentration was lower in people receiving continuous subcutaneous insulin infusion compared with those receiving insulin injections (standardised mean difference 0.56, 95% confidence interval 0.35 to 0.77), equivalent to a difference of 1.0 mmol/l. The percentage of glycated haemoglobin was also lower in people receiving insulin infusion (0.44, 0.20 to 0.69), equivalent to a difference of 0.51%. Blood glucose concentrations were less variable during insulin infusion. This improved control during insulin infusion was achieved with an average reduction of 14% in insulin dose (difference in total daily insulin dose 0.58, 0.34 to 0.83), equivalent to 7.58 units/day. Conclusions: Glycaemic control is better during continuous subcutaneous insulin infusion compared with optimised injection therapy, and less insulin is needed to achieve this level of strict control. The difference in control between the two methods is small but should reduce the risk of microvascular complications. What is already known on this topic: Continuous subcutaneous insulin infusion (insulin pump therapy) produces good long term control of blood glucose concentrations in people with type 1 diabetes Control of blood glucose concentration is substantially better on pump therapy than conventional (non-optimised) injection therapy It is unclear how glycaemic control on pump therapy compares with modern optimised insulin injection regimens What this study adds: Though glycaemic control was better during continuous subcutaneous insulin infusion than optimised insulin injection therapy, the difference was relatively small Continuous subcutaneous insulin infusion is an effective form of intensive insulin therapy that should lower the risk of microvascular complications Insulin pump therapy is unnecessary for most people with type 1 diabetes and should be reserved for those with special problems with optimised insulin injections
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Diabetes Control and Complications Trial (DCCT) Research Group (1996) · Diabetes · doi:10.2337/diab.45.10.1289 · Cited by 597
Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
Pickup, J. C., Keen, H., Parsons, J. A., & Alberti, K. G. (1978) · BMJ · doi:10.1136/bmj.1.6107.204 · Cited by 563
Self-citationThe Kroc Collaborative Study Group* (1984) · New England Journal of Medicine · doi:10.1056/nejm198408093110604 · Cited by 468
Boland, E. A., Grey, M., Oesterle, A., Fredrickson, L., & Tamborlane, W. V. (1999) · Diabetes Care · doi:10.2337/diacare.22.11.1779 · Cited by 432
EFFECT OF 1 YEAR OF NEAR-NORMAL BLOOD GLUCOSE LEVELS ON RETINOPATHY IN INSULIN-DEPENDENT DIABETICS
Lauritzen, T., Larsen, H.-W., Frost-Larsen, K., Deckert, T., & The Steno Study Group (1983) · The Lancet · doi:10.1016/s0140-6736(83)92585-0 · Cited by 373
Dahl-Jorgensen, K., Brinchmann-Hansen, O., Hanssen, K. F., Ganes, T., Kierulf, P., Smeland, E., Sandvik, L., & Aagenaes, O. (1986) · BMJ · doi:10.1136/bmj.293.6556.1195 · Cited by 329
Insulin Lispro in CSII: Results of a Double-Blind Crossover Study
Zinman, B., Tildesley, H., Chiasson, J.-L., Tsui, E., & Strack, T. (1997) · Diabetes · doi:10.2337/diab.46.3.440 · Cited by 258
Cited by
(2007) · Endocrine Practice · doi:10.4158/ep.13.s1.1 · Cited by 699
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 617
Self-citationMisso, M. L., Egberts, K. J., Page, M., O'Connor, D., & Shaw, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005103.pub2 · Cited by 406
Jeitler, K., Horvath, K., Berghold, A., Gratzer, T. W., Neeser, K., Pieber, T. R., & Siebenhofer, A. (2008) · Diabetologia · doi:10.1007/s00125-008-0974-3 · Cited by 375
Hermansen, K., Fontaine, P., Kukolja, K. K., Peterkova, V., Leth, G., & Gall, M.-A. (2004) · Diabetologia · doi:10.1007/s00125-004-1365-z · Cited by 365
Use of Insulin Pump Therapy in the Pediatric Age-Group
Phillip, M., Battelino, T., Rodriguez, H., Danne, T., Kaufman, F., & participants, F. T. C. F. (2007) · Diabetes Care · doi:10.2337/dc07-9922 · Cited by 316
Insulin delivery methods: Past, present and future
Shah, R., Shah, V., Patel, M., & Maahs, D. (2016) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.176456 · Cited by 287
Insulin-pump therapy for type 1 diabetes mellitus
Pickup, J. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1113948 · Cited by 270
Self-citationHoogma, R. P. L. M., Hammond, P. J., Gomis, R., Kerr, D., Bruttomesso, D., Bouter, K. P., Wiefels, K. J., De La Calle, H., Schweitzer, D. H., Pfohl, M., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01738.x · Cited by 255
Farrar, D., Tuffnell, D. J., West, J., & West, H. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005542.pub3 · Cited by 194
Beck, R. W., Riddlesworth, T. D., Ruedy, K. J., Kollman, C., Ahmann, A. J., Bergenstal, R. M., Bhargava, A., Bode, B. W., Haller, S., Kruger, D. F., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30217-6 · Cited by 119
Bolli, G. B., Kerr, D., Thomas, R., Torlone, E., Sola-Gazagnes, A., Vitacolonna, E., Selam, J. L., & Home, P. D. (2009) · Diabetes Care · doi:10.2337/dc08-1874 · Cited by 119
Pala, L., Dicembrini, I., & Mannucci, E. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01326-5 · Cited by 112
Ismail, K., Thomas, S. M., Maissi, E., Chalder, T., Schmidt, U., Bartlett, J., Patel, A., Dickens, C. M., Creed, F., & Treasure, J. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00005 · Cited by 91
Randomized Trial of Infusion Set Function: Steel Versus Teflon
Patel, P. J., Benasi, K., Ferrari, G., Evans, M. G., Shanmugham, S., Wilson, D. M., & Buckingham, B. A. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0119 · Cited by 90
“Meta-analyses of CSII therapy compared with multiple daily injections therapy have shown a modest improvement in glycemic control and a lower incidence of hypoglycemia with CSII therapy.(1,2) Major disadvantages of pump use include infusion set failure, which can lead to hyperglycemia and diabetic ketoacidosis, and lo…”
MethodPańkowska, E., Szypowska, A., Lipka, M., Szpotańska, M., Błazik, M., & Groele, L. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00471.x · Cited by 88
Roze, S., Smith‐Palmer, J., Valentine, W., de Portu, S., Nørgaard, K., & Pickup, J. C. (2015) · Diabetic Medicine · doi:10.1111/dme.12792 · Cited by 77
Self-citationHeller, S., White, D., Lee, E., Lawton, J., Pollard, D., Waugh, N., Amiel, S., Barnard, K., Beckwith, A., Brennan, A., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21200 · Cited by 73
Glycemic Parameters with Multiple Daily Injections Using Insulin Glargine Versus Insulin Pump
Garg, S. K., Walker, A. J., Hoff, H. K., D'Souza, A. O., Gottlieb, P. A., & Chase, H. P. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504322783350 · Cited by 60
Berghaeuser, M., Kapellen, T., Heidtmann, B., Haberland, H., Klinkert, C., Holl, R., & for the DPV-Science-Initiative and the German working group for insulin pump treatment in paediatric patients (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00416.x · Cited by 58
Bode, B. W. (2011) · Endocrine Practice · doi:10.4158/ep10260.ra · Cited by 56
Evolution of Devices in Diabetes Management
Penfornis, A., Personeni, E., & Borot, S. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0058 · Cited by 49
Little, S. A., Leelarathna, L., Barendse, S. M., Walkinshaw, E., Tan, H. K., Lubina Solomon, A., de Zoysa, N., Rogers, H., Choudhary, P., Amiel, S. A., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2492 · Cited by 48
Davis, S. N., Horton, E. S., Battelino, T., Rubin, R. R., Schulman, K. A., & Tamborlane, W. V. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0145 · Cited by 40
Grossesse et diabète de type 1 : pompe à insuline versus traitement intensifié conventionnel
Hiéronimus, S., Cupelli, C., Bongain, A., Durand-Réville, M., Berthier, F., & Fénichel, P. (2005) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2005.04.020 · Cited by 36
Christensen, M. O., Berg, A. K., Rytter, K., Hommel, E., Thyssen, J. P., Svensson, J., & Nørgaard, K. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0007 · Cited by 28
Aleppo, G., DeSalvo, D. J., Lauand, F., Huyett, L. M., Chang, A., Vienneau, T., & Ly, T. T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01366-9 · Cited by 19
Hoshina, S., Andersen, G. S., Jørgensen, M. E., Ridderstråle, M., Vistisen, D., & Andersen, H. U. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0231 · Cited by 18
Xu, S., Alexander, K., Bryant, W., Cohen, N., Craig, M. E., Forbes, M., Fulcher, G., Greenaway, T., Harrison, N., Holmes‐Walker, D. J., et al. (2015) · Internal Medicine Journal · doi:10.1111/imj.12619 · Cited by 13
Metadata
- Authors
- Pickup, J., Mattock, M., & Kerry, S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2002-03-23
- Volume
- 324
- Issue
- 7339
- Pages
- 705
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2131439934
- Cited by
- 483
- References
- 38
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.